Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 17, 2018

DrugPatentWatch Database Preview

Human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant - Biologic Drug Details

« Back to Dashboard

Summary for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant

Tradenames:	1
Patents:	5
Applicants:	1
BLAs:	1
Suppliers: see list	1

US Patents for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Merck Sharp & Dohme Corp.	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	➤ Try a Free Trial	Chevron Phillips Chemical Company LP (The Woodlands, TX)	➤ Try a Free Trial			search
Merck Sharp & Dohme Corp.	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	➤ Try a Free Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	➤ Try a Free Trial			search
Merck Sharp & Dohme Corp.	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	➤ Try a Free Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	➤ Try a Free Trial			search
Merck Sharp & Dohme Corp.	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	➤ Try a Free Trial	ALDERBIO HOLDINGS LLC (Las Vegas, NV)	➤ Try a Free Trial			search
Merck Sharp & Dohme Corp.	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	➤ Try a Free Trial	Progenra, Inc. (Malvern, PA) The Children\'s Hospital of Philadelphia (Philadelphia, PA)	➤ Try a Free Trial			search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
South Korea	20170036814	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2011066371	➤ Try a Free Trial
South Korea	20120118088	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2008144753	➤ Try a Free Trial
China	102292449	➤ Try a Free Trial
Israel	195285	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2015 00043	Denmark	➤ Try a Free Trial	PRODUCT NAME: TRASTUZUMAB OG REKOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: C(20135603) /EU/1/00/145/002 20130826
C0024	France	➤ Try a Free Trial	PRODUCT NAME: NATALIZUMAB,ANTICORPS MONOCLONAL HUMANISE ANTI-INTEGRINE ALPHA-4; REGISTRATION NO/DATE: EU/1/06/346/001 20060627
C/GB02/026	United Kingdom	➤ Try a Free Trial	PRODUCT NAME: ANAKINRA (ALSO KNOWN AS HUMAN IL-1RA); REGISTERED: UK EU/1/02/203/001 20020308; UK EU/1/02/203/002 20020308; UK EU/1/02/203/003 20020308; UK EU/1/02/203/004 20020308
2016 00031	Denmark	➤ Try a Free Trial	PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: EU/1/98/067 20140326
C/GB94/014	United Kingdom	➤ Try a Free Trial	PRODUCT NAME: RECOMBINANT HUMAN FACTOR- VIII (BHK); REGISTERED: NL 16789 19940419; NL 16790 19940419; NL 16791 19940419; UK 0010/0194 19940517; UK 0010/0195 19940517; UK 0010/0196 19940517
2015000061	Germany	➤ Try a Free Trial	PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust

Covington

Cipla

AstraZeneca

Cantor Fitzgerald

Express Scripts

Chinese Patent Office

Deloitte

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.